Liang YJ - Search Results

1

Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.

Liang YJ. Liang YJ. Glycoconj J. 2022 Apr;39(2):177-195. doi: 10.1007/s10719-021-10032-w. Epub 2022 Mar 10. Glycoconj J. 2022. PMID: 35267131 Review.

2

Switching of the core structures of glycosphingolipids from globo- and lacto- to ganglio-series upon human embryonic stem cell differentiation.

Liang YJ, Kuo HH, Lin CH, Chen YY, Yang BC, Cheng YY, Yu AL, Khoo KH, Yu J. Liang YJ, et al. Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22564-9. doi: 10.1073/pnas.1007290108. Epub 2010 Dec 13. Proc Natl Acad Sci U S A. 2010. PMID: 21149694 Free PMC article.

3

Changes in glycosphingolipid composition during differentiation of human embryonic stem cells to ectodermal or endodermal lineages.

Liang YJ, Yang BC, Chen JM, Lin YH, Huang CL, Cheng YY, Hsu CY, Khoo KH, Shen CN, Yu J. Liang YJ, et al. Stem Cells. 2011 Dec;29(12):1995-2004. doi: 10.1002/stem.750. Stem Cells. 2011. PMID: 21956927

4

Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.

Liang YJ, Wang CY, Wang IA, Chen YW, Li LT, Lin CY, Ho MY, Chou TL, Wang YH, Chiou SP, Lin YJ, Yu J. Liang YJ, et al. Oncotarget. 2017 Jul 18;8(29):47454-47473. doi: 10.18632/oncotarget.17665. Oncotarget. 2017. PMID: 28537895 Free PMC article.

5

Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance.

Chang YS, Su CW, Chen SC, Chen YY, Liang YJ, Wu JC. Chang YS, et al. Among authors: liang yj. Cells. 2022 Feb 11;11(4):634. doi: 10.3390/cells11040634. Cells. 2022. PMID: 35203285 Free PMC article.

6

FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.

Cheng KC, Lin RJ, Cheng JY, Wang SH, Yu JC, Wu JC, Liang YJ, Hsu HM, Yu J, Yu AL. Cheng KC, et al. Among authors: liang yj. EBioMedicine. 2019 Jul;45:25-38. doi: 10.1016/j.ebiom.2019.06.022. Epub 2019 Jun 28. EBioMedicine. 2019. PMID: 31262713 Free PMC article.

7

Gene coexpression network analysis identifies hubs in hepatitis B virus-associated hepatocellular carcinoma.

Wang SY, Huang YH, Liang YJ, Wu JC. Wang SY, et al. Among authors: liang yj. J Chin Med Assoc. 2022 Oct 1;85(10):972-980. doi: 10.1097/JCMA.0000000000000772. Epub 2022 Jul 8. J Chin Med Assoc. 2022. PMID: 35801949

8

High Expression of MicroRNA-196a is Associated with Progression of Hepatocellular Carcinoma in Younger Patients.

Wang SY, Chen CL, Hu YC, Chi Y, Huang YH, Su CW, Jeng WJ, Liang YJ, Wu JC. Wang SY, et al. Among authors: liang yj. Cancers (Basel). 2019 Oct 13;11(10):1549. doi: 10.3390/cancers11101549. Cancers (Basel). 2019. PMID: 31614906 Free PMC article.

9

Statin inhibits large hepatitis delta antigen-Smad3 -twist-mediated epithelial-to-mesenchymal transition and hepatitis D virus secretion.

Liang YJ, Sun CP, Hsu YC, Chen YW, Wang IA, Su CW, Tao MH, Wu JC. Liang YJ, et al. J Biomed Sci. 2020 May 21;27(1):65. doi: 10.1186/s12929-020-00659-6. J Biomed Sci. 2020. PMID: 32434501 Free PMC article.

10

Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes.

Chen CL, Tsai YS, Huang YH, Liang YJ, Sun YY, Su CW, Chau GY, Yeh YC, Chang YS, Hu JT, Wu JC. Chen CL, et al. Among authors: liang yj. Hepatol Commun. 2018 Sep 28;2(11):1392-1407. doi: 10.1002/hep4.1229. eCollection 2018 Nov. Hepatol Commun. 2018. PMID: 30411085 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters